Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Test-retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains.

Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther MA, Iorio A.

Haemophilia. 2018 Dec 6. doi: 10.1111/hae.13649. [Epub ahead of print]

PMID:
30520534
2.

Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire.

Chai-Adisaksopha C, Skinner MW, Curtis R, Frick N, Nichol MB, Noone D, O'Mahony B, Page D, Stonebraker J, Thabane L, Crowther M, Iorio A.

BMJ Open. 2018 Aug 8;8(8):e021900. doi: 10.1136/bmjopen-2018-021900.

3.

Real-world comparative analysis of bleeding complications and health-related quality of life in patients with haemophilia A and haemophilia B.

Booth J, Oladapo A, Walsh S, O'Hara J, Carroll L, Garcia Diego DA, O'Mahony B.

Haemophilia. 2018 Sep;24(5):e322-e327. doi: 10.1111/hae.13596. Epub 2018 Aug 9.

PMID:
30091822
4.

Value of prophylaxis vs on-demand treatment: Application of a value framework in hemophilia.

Nugent D, O'Mahony B, Dolan G; International Haemophilia Access Strategy Council.

Haemophilia. 2018 Sep;24(5):755-765. doi: 10.1111/hae.13589. Epub 2018 Aug 8.

PMID:
30088692
5.

Core outcome set for gene therapy in haemophilia: Results of the coreHEM multistakeholder project.

Iorio A, Skinner MW, Clearfield E, Messner D, Pierce GF, Witkop M, Tunis S; coreHEM panel.

Haemophilia. 2018 Jul;24(4):e167-e172. doi: 10.1111/hae.13504. Epub 2018 May 20.

PMID:
29781145
6.

The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands.

Berntorp E, Hart D, Mancuso ME, d'Oiron R, Perry D, O'Mahony B, Kaczmarek R, Crato M, Pasi J, Miners A, Carlsson KS, Kitchen S, Boehlen F, Giangrande P, Cebura E, Uitslager N, Osooli M, Janeckova D, Haldon R, Rivolta GF.

Eur J Haematol. 2016 Jul;97 Suppl 83:3-18. doi: 10.1111/ejh.12760. Erratum in: Eur J Haematol. 2016 Dec;97(6):594.

PMID:
27272000
7.

Managing Haemophilia for Life: 5th Haemophilia Global Summit.

Hermans C, Dolan G, Jennings I, Windyga J, Lobet S, Rodríguez-Merchán EC, Di Minno MN, Jiménez-Yuste V, O'Mahony B.

Eur J Haematol. 2015 Oct;95 Suppl 78:1-25. doi: 10.1111/ejh.12617.

PMID:
26350039
8.

Improving haemophilia patient care through sharing best practice.

de Moerloose P, Arnberg D, O'Mahony B, Colvin B.

Eur J Haematol. 2015 Oct;95 Suppl 79:1-8. doi: 10.1111/ejh.12630.

PMID:
26338268
9.

Issues in assessing products for the treatment of hemophilia - the intersection between efficacy, economics, and ethics.

Farrugia A, Noone D, Schlenkrich U, Schlenkrich S, O'Mahony B, Cassar J.

J Blood Med. 2015 Jun 15;6:185-95. doi: 10.2147/JBM.S79091. eCollection 2015.

10.

Reply to: The importance and challenge of pediatric trials of hemophilia drugs.

Peyvandi F, Rosendaal FR, O'Mahony B, Mannucci PM.

Nat Med. 2014 May;20(5):466. doi: 10.1038/nm.3551. No abstract available.

PMID:
24804749
12.

Pediatric requirements in Europe stymie help for hemophilia.

Peyvandi F, Rosendaal FR, O'Mahony B, Mannuccio Mannucci P.

Nat Med. 2014 Feb;20(2):117. doi: 10.1038/nm0214-117. No abstract available. Erratum in: Nat Med. 2014 Apr;20(4):327.

PMID:
24504399
13.

The Dublin Consensus Statement 2012 on optimised supply of plasma-derived medicinal products.

O'Mahony B.

Blood Transfus. 2013 Oct;11(4):623-6. doi: 10.2450/2013.0044-13. Epub 2013 Jul 26. No abstract available.

14.

Pfizer-sponsored satellite symposium at the European Haemophilia Consortium (EHC) congress. Understanding health outcomes: focus on haemophilia.

Colvin B, Dolan G, Martinoli C, O'Mahony B.

Eur J Haematol Suppl. 2013 May;(73):1-9. doi: 10.1111/ejh.12093.

PMID:
23570445
15.

Expanding hemophilia care in developing countries.

O'Mahony B, Black C.

Semin Thromb Hemost. 2005 Nov;31(5):561-8. Review.

PMID:
16276465

Supplemental Content

Loading ...
Support Center